Literature DB >> 18272665

Kinetics of recombinant adenovirus type 5, vaccinia virus, modified vaccinia ankara virus, and DNA antigen expression in vivo and the induction of memory T-lymphocyte responses.

Ralf Geiben-Lynn1, John R Greenland, Kwesi Frimpong-Boateng, Norman L Letvin.   

Abstract

While a new generation of vaccine vectors has been developed for eliciting cellular immune responses, little is known about the optimal routes for their administration or about the ramifications of the kinetics of in vivo vaccine antigen expression for immunogenicity. We evaluated the kinetics of vaccine antigen expression by real-time in vivo photon imaging and showed dramatic differences in these kinetics using different vectors and different routes of administration. Further, using a gamma interferon enzyme-linked immunospot assay to measure T-lymphocyte immune responses, we observed an association between the kinetics of vaccine antigen expression in vivo and the magnitude of vaccine-elicited memory T-lymphocyte responses. These results highlight the utility of the real-time in vivo photon-imaging technology in evaluating novel immunization strategies and suggest an association between the kinetics of vaccine antigen clearance and the magnitude of vaccine-elicited T-lymphocyte memory immune responses.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18272665      PMCID: PMC2292663          DOI: 10.1128/CVI.00418-07

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


  25 in total

Review 1.  Ethical decision making about animal experiments.

Authors:  F Barbara Orlans
Journal:  Ethics Behav       Date:  1997

Review 2.  Gene transfer vector biodistribution: pivotal safety studies in clinical gene therapy development.

Authors:  P Gonin; C Gaillard
Journal:  Gene Ther       Date:  2004-10       Impact factor: 5.250

3.  Induction of HLA-DR expression on human myoblasts with interferon-gamma.

Authors:  R Hohlfeld; A G Engel
Journal:  Am J Pathol       Date:  1990-03       Impact factor: 4.307

4.  Detection of HIV vaccine-induced cell-mediated immunity in HIV-seronegative clinical trial participants using an optimized and validated enzyme-linked immunospot assay.

Authors:  Sheri Dubey; James Clair; Tong-Ming Fu; Liming Guan; Romnie Long; Robin Mogg; Kiersten Anderson; Kelly B Collins; Christine Gaunt; V Rose Fernandez; Lan Zhu; Lisa Kierstead; Scott Thaler; Swati B Gupta; Walter Straus; Devan Mehrotra; Timothy W Tobery; Danilo R Casimiro; John W Shiver
Journal:  J Acquir Immune Defic Syndr       Date:  2007-05-01       Impact factor: 3.731

5.  Disseminated vaccinia in a military recruit with human immunodeficiency virus (HIV) disease.

Authors:  R R Redfield; D C Wright; W D James; T S Jones; C Brown; D S Burke
Journal:  N Engl J Med       Date:  1987-03-12       Impact factor: 91.245

6.  Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity.

Authors:  John W Shiver; Tong-Ming Fu; Ling Chen; Danilo R Casimiro; Mary-Ellen Davies; Robert K Evans; Zhi-Qiang Zhang; Adam J Simon; Wendy L Trigona; Sheri A Dubey; Lingyi Huang; Virginia A Harris; Romnie S Long; Xiaoping Liang; Larry Handt; William A Schleif; Lan Zhu; Daniel C Freed; Natasha V Persaud; Liming Guan; Kara S Punt; Aimin Tang; Minchun Chen; Keith A Wilson; Kelly B Collins; Gwendolyn J Heidecker; V Rose Fernandez; Helen C Perry; Joseph G Joyce; Karen M Grimm; James C Cook; Paul M Keller; Denise S Kresock; Henryk Mach; Robert D Troutman; Lynne A Isopi; Donna M Williams; Zheng Xu; Kathryn E Bohannon; David B Volkin; David C Montefiori; Ayako Miura; Georgia R Krivulka; Michelle A Lifton; Marcelo J Kuroda; Jörn E Schmitz; Norman L Letvin; Michael J Caulfield; Andrew J Bett; Rima Youil; David C Kaslow; Emilio A Emini
Journal:  Nature       Date:  2002-01-17       Impact factor: 49.962

7.  Elevated MHC class I and II antigens in cultured human embryonic myoblasts following stimulation with gamma-interferon.

Authors:  S S Bao; N J King; C G dos Remedios
Journal:  Immunol Cell Biol       Date:  1990-08       Impact factor: 5.126

8.  Luciferase imaging of a neurotropic viral infection in intact animals.

Authors:  Susan H Cook; Diane E Griffin
Journal:  J Virol       Date:  2003-05       Impact factor: 5.103

9.  Expression of the firefly luciferase gene in vaccinia virus: a highly sensitive gene marker to follow virus dissemination in tissues of infected animals.

Authors:  J F Rodriguez; D Rodriguez; J R Rodriguez; E B McGowan; M Esteban
Journal:  Proc Natl Acad Sci U S A       Date:  1988-03       Impact factor: 11.205

10.  Immunogenicity of recombinant adenovirus serotype 35 vaccine in the presence of pre-existing anti-Ad5 immunity.

Authors:  Dan H Barouch; Maria G Pau; Jerome H H V Custers; Wouter Koudstaal; Stefan Kostense; Menzo J E Havenga; Diana M Truitt; Shawn M Sumida; Michael G Kishko; Janelle C Arthur; Birgit Korioth-Schmitz; Michael H Newberg; Darci A Gorgone; Michelle A Lifton; Dennis L Panicali; Gary J Nabel; Norman L Letvin; Jaap Goudsmit
Journal:  J Immunol       Date:  2004-05-15       Impact factor: 5.422

View more
  29 in total

Review 1.  Viruses as vaccine vectors for infectious diseases and cancer.

Authors:  Simon J Draper; Jonathan L Heeney
Journal:  Nat Rev Microbiol       Date:  2010-01       Impact factor: 60.633

2.  Non-classical natural killer T cells modulate plasmid DNA vaccine antigen expression and vaccine-elicited immune responses by MCP-1 secretion after interaction with a beta2-microglobulin-independent CD1d.

Authors:  Ralf Geiben-Lynn; John R Greenland; Kwesi Frimpong-Boateng; Norman L Letvin
Journal:  J Biol Chem       Date:  2009-10-15       Impact factor: 5.157

Review 3.  Enhancing poxvirus vectors vaccine immunogenicity.

Authors:  Juan García-Arriaza; Mariano Esteban
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

4.  Induction of both cellular and humoral immunity following a rational prime-boost immunization regimen that incorporates recombinant ovine atadenovirus and fowlpox virus.

Authors:  Cara K Fraser; Kerrilyn R Diener; Erin L Lousberg; Gerald W Both; Larry Ward; Michael P Brown; John D Hayball
Journal:  Clin Vaccine Immunol       Date:  2010-09-01

5.  CD8+ T effector memory cells protect against liver-stage malaria.

Authors:  Arturo Reyes-Sandoval; David H Wyllie; Karolis Bauza; Anita Milicic; Emily K Forbes; Christine S Rollier; Adrian V S Hill
Journal:  J Immunol       Date:  2011-06-29       Impact factor: 5.422

6.  Deletion of Fifteen Open Reading Frames from Modified Vaccinia Virus Ankara Fails to Improve Immunogenicity.

Authors:  Naif Khalaf Alharbi; Alexandra J Spencer; Adrian V S Hill; Sarah C Gilbert
Journal:  PLoS One       Date:  2015-06-08       Impact factor: 3.240

7.  Anti-gamma interferon antibodies enhance the immunogenicity of recombinant adenovirus vectors.

Authors:  Shawn S Jackson; Jörn E Schmitz; Norman L Letvin
Journal:  Clin Vaccine Immunol       Date:  2011-09-07

8.  Potent and broadly reactive HIV-2 neutralizing antibodies elicited by a vaccinia virus vector prime-C2V3C3 polypeptide boost immunization strategy.

Authors:  José Maria Marcelino; Pedro Borrego; Cheila Rocha; Helena Barroso; Alexandre Quintas; Carlos Novo; Nuno Taveira
Journal:  J Virol       Date:  2010-09-15       Impact factor: 5.103

9.  Mucosal delivery of human papillomavirus pseudovirus-encapsidated plasmids improves the potency of DNA vaccination.

Authors:  B S Graham; R C Kines; K S Corbett; J Nicewonger; T R Johnson; M Chen; D LaVigne; J N Roberts; N Cuburu; J T Schiller; C B Buck
Journal:  Mucosal Immunol       Date:  2010-06-16       Impact factor: 7.313

10.  Regulatory T cells suppress natural killer cells during plasmid DNA vaccination in mice, blunting the CD8+ T cell immune response by the cytokine TGFbeta.

Authors:  Kwesi Frimpong-Boateng; Nico van Rooijen; Ralf Geiben-Lynn
Journal:  PLoS One       Date:  2010-08-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.